CRO Activity & Intelligence Report
BioPharm Insight is your definitive guide to the global life sciences community, combining an online business intelligence system of comprehensive market analytics and key industry contacts with an independent investigative journalism news service.
BioPharm Insight consists of an acclaimed independent journalist team with a proven track record of breaking forward-looking and competitive business intelligence 6-12 months ahead of mainstream press. Based in our news bureaus in New York and London, reporters conduct in-depth interviews with subject matter experts to ensure subscribers take action on reliable global intelligence.
Market Analytics & Key Industry Contacts
Featuring an intuitive user interface, precise custom searches, real-time alerts, unrivaled personal support and exclusive Active Intel technology linking data with intelligence, BioPharm Insight is an online system providing subscribers with robust market analytics and a comprehensive database of:
- 615,000 management and R&D contacts
- 7,000 biopharma companies with full pipeline data
- 350,000 investigational and approved drug profiles
- 15,000 M&A and licensing deals
- 7,000 extended sales forecasts
- Epidemiology profiles for hundreds of indications
In the News
Big pharma gets creative as deals spike in 1H14
Surani Fernando, editor at BioPharm Insight, talks about how drug pricing pressure and patent cliffs force big pharma to think outside the deal-making box.